1. Home
  2. DSS vs SILO Comparison

DSS vs SILO Comparison

Compare DSS & SILO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DSS Inc.

DSS

DSS Inc.

HOLD

Current Price

$0.98

Market Cap

9.1M

ML Signal

HOLD

Logo Silo Pharma Inc.

SILO

Silo Pharma Inc.

HOLD

Current Price

$0.41

Market Cap

8.0M

ML Signal

HOLD

Company Overview

Basic Information
Metric
DSS
SILO
Founded
1984
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Containers/Packaging
Apparel
Sector
Consumer Discretionary
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.1M
8.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
DSS
SILO
Price
$0.98
$0.41
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
7.3K
132.6K
Earning Date
11-14-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,046,000.00
$72,102.00
Revenue This Year
$14.93
$1.86
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
6.53
N/A
52 Week Low
$0.72
$0.36
52 Week High
$1.90
$3.37

Technical Indicators

Market Signals
Indicator
DSS
SILO
Relative Strength Index (RSI) 38.01 36.44
Support Level $0.98 $0.42
Resistance Level $1.08 $0.46
Average True Range (ATR) 0.05 0.02
MACD 0.00 0.00
Stochastic Oscillator 0.06 2.22

Price Performance

Historical Comparison
DSS
SILO

About DSS DSS Inc.

DSS Inc is operating a business focused on Five operating segments Product Packaging, Biotechnology, Commercial Lending, Securities and Investment Management, and Direct Marketing. Currently operates five distinct business lines operate around the globe with primary operations in North America and Asia. Product packaging manufactures, and sells sophisticated custom folding cartons, mailers, photo sleeves and complex three-dimensional direct mail solutions. Biotechnology division targets unmet, urgent medical needs and expands the borders of medical and pharmaceutical science. Commercial Lending through represents its banking and financing business line. Alternative Trading develops and/or acquires assets and investments in the securities trading and/or fund management arena.

About SILO Silo Pharma Inc.

SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's primary program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.

Share on Social Networks: